Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitro.

Podobne knjige/članki

• In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
  od: Stamm, J M, et al.
  Izdano: (1986)
• In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.
  od: Liebowitz, L D, et al.
  Izdano: (1986)
• Aryl-fluoroquinolone derivatives A-56619 (difloxacin) and A-56620 inhibit mitogen-induced human mononuclear cell proliferation.
  od: Gollapudi, S V, et al.
  Izdano: (1986)
• Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess.
  od: Thadepalli, H, et al.
  Izdano: (1986)
• Factors influencing the in vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620.
  od: Hirschhorn, L, et al.
  Izdano: (1986)